Inovio Pharmaceuticals, Inc. (NASDAQ: INO) does have a beta rating of 1.34 and it has reported 76,218,903 shares exchanged at the last stock market. The business, today’s price at $2.5 billion, ended the very last trade at $15.79 each share, this means that this won $1.2 a day or 8.45 a cent mostly during the session. INO’s market price is-22.61 percent from its 52-week steep cost of $19.36 and 87.84 percent well above the 52-week reduced price of $1.92. read more